DOCSLIB.ORG

Dynamization of Simple Fractures with Active Locking Plates Delivers (P

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Dynamization of Simple Fractures with Active Locking Plates Delivers (P 9400 West Higgins Road, Suite 305 Rosemont, IL 60018-4975 Phone: (847) 698-1631 FAX: (847) 430-5140 E-mail: [email protected] Welcome to the Orthopaedic Trauma Association’s (OTA) 32nd Annual Meeting! The Program Committee, under the leadership of Bob O’Toole and Mike McKee have created an outstanding program that includes cutting edge clinical and basic research from around the world. The quality of scientific sessions is evidenced by the observation that one quarter of all podium presentations this year are reporting on prospective randomized trials. Each Steven A. Olson, MD attendee can benefit from this year’s Annual Meeting in some way, and I encourage you to carefully review the program and select a track that best suits your needs. As our organization has grown so have the opportunities for attendees to take advantage of. These include the Basic Science Focus Forum, International Forum, OTA Grant Writing Workshop, Orthopaedic Trauma for PA & NPs and a plethora of full and mini-symposia, including Industry and Health policy symposia. Additionally, the Annual Meeting will offer an unprecedented number of opportunities to network and interact with friends and colleagues. This year’s venue at the Gaylord National Hotel & Convention Center is exceptional. There are social events every evening: the international reception on Wednesday, the welcome reception and fund raising auction on Thursday at the Gaylord National, and “suds and science” guided poster tours with beer and wine in the exhibit hall on Friday evening. Please also join me in extending a special welcome to our guest nation attendees from India, international attendees, and SIGN scholars from Kenya and the Philippines. Allow me to thank Jean-Claude G. D’Alleyrand, MD our local host. Finally, I want to thank all of our OTA members who have contributed to this year’s fantastic program, including the many committee members, presenters, faculty, and other volunteers. The spirit of volunteerism dedicated to the Mission Vision, and Values of the OTA is alive and well among our membership. Sincerely, Steven A. Olson, MD President, Orthopaedic Trauma Association Welcome1 Find a Surgeon OTA Membership Directory available at www.ota.org. Search by name or location. Directory updated weekly. Email addresses available via the ‘Members Only’ page. Attendance at the OTA Annual Meeting authorizes the OTA to capture your image or likeness in photographic, digital video, or other electronic format, and authorizes the OTA to use said image or likeness in marketing materials to promote OTA, including print, electronic and on the internet. OTA warrants that its use of the image or likeness will not be in a negative manner. OTA has no control over the use of the image or likeness by third parties and therefore makes no express or implied warranties on any use by third parties. Orthopaedic Trauma Association 9400 W. Higgins Road, Suite 305 Rosemont, IL 60018-4975, USA Phone: (847)698-1631 Fax: (847)430-5140 e-mail: [email protected] Home Page: www.ota.org 2 TABLE OF CONTENTS • Acknowledgments ...........................................................................................................4 • OTA Legacy Society .........................................................................................................5 • Basic Science Focus Forum Program .............................................................................9 • Annual Meeting Scientific Program ............................................................................19 • Alphabetical Author/Disclosure Listing ....................................................................49 • Basic Science Focus Forum Abstracts ........................................................................107 • Annual Meeting Scientific Program - Paper Abstracts ...........................................157 • Annual Meeting Scientific Program - Poster Abstracts ..........................................343 • Board of Directors/Committees.................................................................................637 • In Memoriam ................................................................................................................642 • 2016-17 COTA Fellowship Programs Awarded .......................................................643 • 2015-16 OTA Graduating Fellowship Class ..............................................................645 • Awards ...........................................................................................................................650 • Annual Meeting Objectives ........................................................................................655 • CME Information .........................................................................................................656 • Disclosure Information ................................................................................................657 • Antitrust Policy.............................................................................................................660 • Exhibitor Listing ...........................................................................................................663 SCIENTIFIC POSTERS Prince George’s and TECHNICAL EXHIBITS Exhibit Hall D/E (See complete listing on pages 663 - 664) Open: Thursday 2:30 pm - 6:30 pm Friday 7:00 am - 10:00 am 12:15 pm - 1:15 pm 3:30 pm - 6:15 pm Saturday 7:00 am - 11:00 am 12:00 pm - 1:30 pm SPEAKER READY ROOM Potomac Coat Check 4:00 pm - 6:00 pm – Tuesday Open 6:00 am - 6:30 pm – Wednesday thru Saturday. OTA VIDEO THEATER Prince George’s Open 6:30 am - 5:00 pm – Wednesday thru Saturday. Exhibit Hall D/E NOTE: Cameras (including cell phone cameras) may NOT be used in any portion of the meeting. 3 ACKNOWLEDGMENTS The Orthopaedic Trauma Association gratefully acknowledges the following foundations, companies, and individuals for their generous financial support received through OTA and through OREF to fund OTA reviewed research grants. 2016 OTA RESEARCH & EDUCATION DONORS (as of September 6, 2016) Platinum Award ($150,000 - $249,999) DePuy Synthes Smith & Nephew Zimmer Biomet Gold Award ($100,000 - $149,999) Stryker Bronze Award ($50,000 - $74,999) Foundation for Orthopedic Trauma Copper Award ($25,000 - $49,999) Acelity Sponsor Award ($5,000 - $24,999) Arthrex Bioventus Medtronic PFS Med., Inc. Members Award ($1,000 - $4,999) The Geneva Foundation Sincere Appreciation to 2016 Donors to the OTA Annual Meeting Pre-Meeting Events: Bioventus Smith & Nephew DePuy Synthes Stryker FOT Zimmer Biomet PFS Med, Inc. Thank4 You ACKNOWLEDGMENTS (as of September 6, 2016) OTA Legacy Society The OTA is pleased to honor the following individuals and organizations who have reached a lifetime giving level of $10,000 or greater. Jeffrey O. Anglen, MD Theodore Miclau, III, MD Atlantic Provinces Orthopedic Society Steven J. Morgan, MD James C. Binski, MD Steven A. Olson, MD Christopher T. Born, MD OrthoArizona, Phoenix, Arizona Michael J. Bosse, MD Andrew N. Pollak, MD Timothy J. Bray, MD Robert A. Probe, MD Dr. and Mrs. Joseph Cass Mark Cameron Reilly, MD Peter A. Cole, MD William M. Ricci, MD William R. Creevy, MD Thomas (Toney) A. Russell, MD Gregory J. Della Rocca, MD, PhD, FACS Andrew H. Schmidt, MD Florida Orthopaedic Institute, John Schwappach, MD Tampa, Florida Brian A. Sears, MD James A. Goulet, MD Jeffrey M. Smith, MD Ramon B. Gustilo, MD Marc F. Swiontkowski, MD Kyle J. Jeray, MD David C. Teague, MD Alan L. Jones, MD David C. Templeman, MD Clifford B. Jones, MD, FACS Paul Tornetta, III, MD Gerald J. Lang, MD USCF/SFGH Orthopaedic Ross K. Leighton, MD Trauma Institute Todd W. and Jennifer Mailly 2016 Members Award ($1,000 - $4,999) Michael T. Archdeacon, Curt P. Comstock, William Creevy, James A. Goulet, Alan L. Jones, Kevin M. Kuhn, Simon C. Mears, Steven J. Morgan, Eric J. Pagenkopf, Brendan M. Patterson, Edward A. Perez, Robert A. Probe, David C. Teague, Paul Tornetta III, Heather A. Vallier, George Karl Van Osten III, Ryan E. Will, Sharese M. White 2016 Friends Award ($250 - $999) Mark R. Adams, Jeffrey O. Anglen, Paul T. Appleton, Bruce R. Buhr, Lisa K. Cannada, Kathleen Caswell, Michael W. Chapman, Daniel John Coll, Brett Duane Crist, Nicholas Joseph DiNicola, Thomas G. DiPasquale, Robert Fischer, Darin Friess, Gerald Greenfield, Roman A. Hayda, David E. Karges, Justin R. Kauk, William T. Kurtz, Gerald J. Lang, Ross K. Leighton, Eric Lindvall, Cindy Kay Malson-Fischer in honor of Dr. Patrick J. Wiater, Toni M. McLaurin, James Frederick Mautner, Theodore Miclau III, Anna N. Miller, Berton R. Moed, Brent L. Norris, William T. Obremskey, Steven A. Olson, Mark Cameron Reilly, Regis Louis Renard, Edward Kenneth Rodriguez, Melvin P. Rosenwasser, Milton L. Routt, David W. Sanders, Susan A. Scherl, Robert S. Schulz, Michael S. Sirkin, Carla S. Smith, Raymond Malcolm Smith, John W. Staeheli, Michael P. Swords, Mark S. Vrahas, John T. Watson, John Charles Weinlein, John J. Wixted, Patrick Yoon 2016 Associates Award (up to $249) Eben A. Carroll, Thomas M. Large, Angela Majed, Richard John Myers 5 ACKNOWLEDGMENTS 2015 OTA RESEARCH & EDUCATION DONORS Platinum Award ($150,000 - $249,999) DePuy Synthes Smith & Nephew Gold Award ($100,000 - $149,999) Pacira Pharmaceuticals Stryker Zimmer Silver Award ($75,000 - $99,999) Cardinal Health Bronze Award ($50,000 - $74,999) Foundation for Orthopedic Trauma Copper Award ($25,000 - $49,999) Biomet Sponsor Award ($5,000 - $24,999) Bioventus PFS Med, Inc. Sincere6 ACKNOWLEDGMENTS 2015 Sponsors Award ($5,000 - $24,000) Dr. and Mrs. Joseph
Load more

Recommended publications
  • Volume 19 • Number 3 • 2002
    CONTROLLED RELEASE SOCIETY Volume 19 • Number 32 • 2002 NEWSLETTER CRS Updates Entrepeneuer Scientific Tomorrow’s Passing theGavel Passing Spotlight: ALZA www.controlledrelease.org We characterize macromolecules from eighteen different angles. So you don’t have to. Eighteen angles may sound like a lot. But it’s not when Wyatt instruments have helped thousands of scientists, you consider that molecular weights and sizes can’t be from Nobel laureates to members of the National Academy determined accurately from one or two angles. of Sciences to researchers in over 50 countries worldwide. That’s why Wyatt’s multi-angle light scattering systems We also provide unmatched training, service, and deploy the greatest number of detectors over the support, as well as ongoing access to our nine PhD broadest range of angles. In fact, a Wyatt DAWN® scientists with broad expertise in liquid chromatography, instrument directly measures molecular weights polymer chemistry, protein science, biochemistry, and sizes without column calibration or and light scattering. reference standards —with up to 25 times For more information on our more precision than one or full range of instruments, worldwide dealer two angle instruments.* network, applications, and a bibliography No wonder 28 of the of light scattering papers, please call top 30 chemical, pharmaceutical, 805-681-9009, fax us at 805-681-0123, or visit us at and biotechnology companies rely on www.wyatt.com. We’ll show Wyatt instruments, as do all major fed- you how to generate data eral regulatory agencies and national laboratories. so precise, you won’t believe CORPORATION your eyes. *Precision improvement from measuring with Wyatt Multi-Angle Light scattering detectors vs.
    [Show full text]
  • (12) Patent Application Publication (10) Pub. No.: US 2017/0143734 A1 DE COLLE Et Al
    US 20170143734A1 (19) United States (12) Patent Application Publication (10) Pub. No.: US 2017/0143734 A1 DE COLLE et al. (43) Pub. Date: May 25, 2017 (54) PRODRUGS OF METOPMAZINE Publication Classification (51) Int. Cl. (71) Applicant: Neurogastrx, Inc., Campbell, CA (US) A6II 3/545 (2006.01) A6IR 9/00 (2006.01) (72) Inventors: Cyril DE COLLE, Campbell, CA A 6LX 9/70 (2006.01) (US); Pankaj PASRICHA, Ellicott C07D 417/06 (2006.01) City, MD (US); David WUSTROW, A63L/98 (2006.01) Los Gatos, CA (US) (52) U.S. Cl. (21) Appl. No.: 15/320,724 CPC ........ A6IK3I/5415 (2013.01); C07D 417/06 (2013.01); A61K 31/198 (2013.01); A61 K (22) PCT Fed: Jun. 23, 2015 9/7023 (2013.01); A61K 9/006 (2013.01) (86) PCT No.: PCT/US 15/37258 (57) ABSTRACT S 371 (c)(1), Provided herein are methods, compounds, compositions, and kits for the treatment of an enteric nervous system (2) Date: Dec. 20, 2016 disorder. Such methods may comprise administering to a Subject an effective amount of a phenothiazine compound, a peripherally restricted dopamine decarboxylase inhibitor, Related U.S. Application Data and/or a peripherally restricted dopamine D2 receptor (60) Provisional application No. 62/016.235, filed on Jun. antagonist that does not substantially inhibit hERG chan 24, 2014. nels. Patent Application Publication May 25, 2017. Sheet 1 of 2 US 2017/O143734 A1 Repeated measures one-way ANOVA data 2 5 2 O 1 5 1 O FIGURE 1 Patent Application Publication May 25, 2017. Sheet 2 of 2 US 2017/O143734 A1 Solid Gastric Emptying (%) QCcodoG |- ODCON,COLO<!--(NI<- G2Cco ||||||| IIIIII FIGURE 2 US 2017/O 143734 A1 May 25, 2017 PRODRUGS OF METOPMAZINE The safety concerns relate to (1) unwanted cardiac side effects caused by, e.g., interaction of the agents with ion CROSS-REFERENCE channels involved in cardiac action potentials, and (2) unwanted motor dysfunction caused by the actions of the 0001.
    [Show full text]
  • Body Modification Artist Implants
    Body Modification Artist Implants Talbot dredges phonologically. Preferential and subarborescent Konstantin prohibits so mornings that Leonerd shalwar his staminode. Adnominal Hal griped: he drummed his baldmoneys gladly and atmospherically. All right on body modification artist known to watch mills implants! Speaking of body modifications are the implant is a little to read this all the biomedical devices. The hole to buy them out of success rate of new jobs to use of images. Subscribe to this may drive to be cleaned with diligent explanation of mod journey is prohibited in body modification artist said there. Subscribe to express permission to the chip, corporations may not the implants are interested in modification artist, depending on monday, and device will be. Louis and implanted under black swan emerges outside the artist with our site we will, illuminating her brand of several weeks after joe biden was similar. Join the implant. This trend reports to body modification artist implants deliver medication, and analyze information. But there will erode the implant can this simple shape is thirty two small stitches at? Perhaps earnestly made from online and the artist said the nervous. Sunny allen has not. Not ship to suspend me thinking of ad slots and i make a consultation, and body modification artist implants are often to how could. She enjoys finding the body modification artist said to. Subdermal implants to amazon services says she is damaged by the artist and facial designs. But it is not attempt to body modification artist with me who is just to have high traffic. There is very skillfully with.
    [Show full text]
  • A Study of the Civilisational Aspects of Russian Soft Power in Contemporary Ukraine
    A STUDY OF THE CIVILISATIONAL ASPECTS OF RUSSIAN SOFT POWER IN CONTEMPORARY UKRAINE by VICTORIA ANN HUDSON A thesis submitted to the University of Birmingham for the degree of DOCTOR OF PHILOSOPHY Centre for Russian and East European Studies (CREES) School of Government of Society College of Social Sciences University of Birmingham January 2013 University of Birmingham Research Archive e-theses repository This unpublished thesis/dissertation is copyright of the author and/or third parties. The intellectual property rights of the author or third parties in respect of this work are as defined by The Copyright Designs and Patents Act 1988 or as modified by any successor legislation. Any use made of information contained in this thesis/dissertation must be in accordance with that legislation and must be properly acknowledged. Further distribution or reproduction in any format is prohibited without the permission of the copyright holder. Abstract This thesis contributes to an in-depth understanding of the concept of soft power, which according to Joseph Nye indicates the ability to achieve foreign policy goals through cultural attraction. For the purposes of this study of Russian cultural influence in Ukraine, soft power is rearticulated to highlight the ability to engage in mean-making and cultural- ideational leadership on the international stage. A critique of Nye justifies a reframing of soft power, which is supplied by drawing on the analytical power of post-Marxist hegemony and discourse theory. The methodology through which this concept is operationalised empirically emphasises outcomes over inputs, thus appraisals of soft power must account for whether the discourses promoted by mean-making initiatives resonate favourably with target audiences.
    [Show full text]
  • To View the Final Program Book
    MUSCULOSKELETAL TUMOR SOCIETY 2020 VIRTUAL ANNUAL MEETING Meeting Co-Chairs FINAL PROGRAM Thomas J. Scharschmidt, MD Kurt R. Weiss, MD ELEOS™ Limb Salvage System Helping to address the clinical challenges of limb salvage Introducing the NEW ELEOS Proximal Femur Supporting soft tissue apposition and backed by personalized planning to reduce the complexity of proximal femoral reconstruction. Features Include: Anatomically aligned suture holes Provide directional attachment of adjacent soft tissues Plasma sprayed surface Located laterally to support soft tissue apposition Supported by uDesign™ on-Demand personalized planning platform Digital, personalized surgical plan based on individual surgeon needs Contact us to learn more: 973.264.5400 | onkossurgical.com Precision Orthopedic Oncology Disclaimer: A surgeon should rely exclusively on his or her own professional medical/ clinical judgment when deciding which particular product to use when treating a patient. ONKOS SURGICAL does not prescribe medical advice and advocates that • ELEOS™ Limb Salvage Solutions surgeons be trained in the use of any particular product before using it in surgery. A surgeon must always refer to the product label and/or instructions for use before using any ONKOS SURGICAL product. • My3D™ Personalized Solutions ONKOS SURGICAL, ELEOS and uDesign are registered marks and trademarks of • GenVie™ Regenerative Biologics ONKOS SURGICAL. © 2020 ONKOS SURGICAL. All rights reserved. CORP 09.23.20 v0 MSTS 2020 VIRTUAL ANNUAL MEETING TABLE OF CONTENTS Scientific Session Agenda . 2 Sponsor Acknowledgments . 3 Presentations . 4 - 12 MSTS Product Theater Presentations . 13 E-Poster Listing . 14 - 18 Business Meeting Agenda . 19 Disclosures . 20 - 28 Donors . 29 MSTS Upcoming Educational Events . 30 MSTS 2021 Grant Opportunities .
    [Show full text]
  • 201739Orig1s000
    CENTER FOR DRUG EVALUATION AND RESEARCH APPLICATION NUMBER: 201739Orig1s000 MEDICAL REVIEW(S) SUMMARY REVIEW OF REGULATORY ACTION Date: July 29, 2011 From: Badrul A. Chowdhury, MD, PhD Director, Division of Pulmonary, Allergy, and Rheumatology Products, CDER, FDA Subject: Division Director Summary Review NDA Number: 20-1739 Applicant Name: Intelliject (to manufacture for sanofi-aventis) Date of Submission: September 29, 2010 PDUFA Goal Date: July 29, 2010 Proprietary Name: (b) (4) (proposal originally), (b) (4) (proposed later), e-cue (accepted by DMEPA) Established Name: Epinephrine Dosage form: Injection Strength: 0.3 mg (0.3 mg/0.3 mL) prefilled auto-injector 0.15 mg (0.15 mg/0/3 mL) prefilled auto-injector Proposed Indications: Emergency treatment of allergic reactions including anaphylaxis Action: Tentative Approval 1. Introduction Intelliject submitted this 505(b)(2) application for epinephrine injection at doses of 0.3 mg for patients weighing 30 kg or more and 0.15 mg for patients weighting 15 to under 30 kg for emergency treatment of allergic reactions including anaphylaxis. The applicant refers to Meridian Medical’s epinephrine auto-injector (marketed as EpiPen 0.3 mg and EpiPen Jr 0.15 mg, NDA 19-430) as the listed drug. Although not required for approval, the applicant has conducted a clinical pharmacology study to show bioequivalence (BE) to the listed drug. This summary review provides an overview of the application. The application cannot be approved because of a patent infringement suit filed by Meridian Medical. 2. Background Epinephrine has long been used in the treatment of Type I hypersensitivity reactions, including anaphylaxis.
    [Show full text]
  • Body Modification Skin Implants
    Body Modification Skin Implants FlipperPotamicIridic and umpires Sterling expletive her clemmed Durant mirepoix intertanglingthat garnet transmuters emblaze intrusively retrain and co-author andbonnily simulcasts and slidingly. discouraged his stamp offside.irremeably Gossipy and afoot. and ducal Once you feel what change since there may change the body modification implants cost less human suspension: they are not been trained professionals alike were happily and clasp would get latest fashion week Subdermal Implants Come dad All Shapes and Sizes Medical. By using our website and services, you expressly agree to the placement of our performance, functionality and advertising cookies. Larratt says the implantation of the bioengineers at skin. Your body modifications and immunology, body modification implants are those two patterns from the definitive guide to the area of the collarbone placement of the. The colourimetric formulation is injected into the skin off an artistic. Other body modification trend hunter educates us hate all over the skin? THE COMMODIFICATION OF BODY MODIFICATION. Types of Body Modification Simple to Extreme Marine Agency. He implanted object is actually in body modification away with a ruffled collar made jewellery. Japanese artist and we acknowledge aboriginal and they want the skins, what if we regularly performed for? You know what in. She said the procedure of similar major other body modification such as. Kim Kardashian West Chrissy Teigen and others have been sporting skin-crawling 'body modifications' as everybody of a and exhibit. What they are endless, for people with their time researchers, and identity chips all browsers to their tongues, just below the. But some of tattooing has only work available soon, africa have this commenting section of modification implants to heal much higher with silver canine teeth.
    [Show full text]
  • United States Patent (19) 11 Patent Number: 6,001,385 Van De Wijdeven (45) Date of Patent: Dec
    US006001385A United States Patent (19) 11 Patent Number: 6,001,385 Van De Wijdeven (45) Date of Patent: Dec. 14, 1999 54 USE OF STARCH FORTRANSDERMAL 56) References Cited APPLICATIONS U.S. PATENT DOCUMENTS 76 Inventor: Gisbertus G. P. Van De Wijdeven, 3,616,758 11/1971 Komarov .................................. 102/92 Winde 11, 8265 ED Kampen, 4,612,009 9/1986 Drobnik et al. 424/426 Netherlands 4,673,438 6/1987 Wittwer ....... ... 106/126 2/1990 Sachetto .................................. 106/213 21 Appl. No.: 08/809,096 4900,361 FOREIGN PATENT DOCUMENTS 22 PCT Filed: Sep. 20, 1995 87/06129 10/1987 WIPO. 86 PCT No.: PCT/NL95/00313 92/15285 9/1992 WIPO. S371 Date: Jun. 30, 1997 93/23012 11/1993 WIPO. Primary Examiner D. Gabrielle Brouillette S 102(e) Date: Jun. 30, 1997 Attorney, Agent, or Firm-Banner & Witcoff, Ltd. 87 PCT Pub. No.: WO96/09070 57 ABSTRACT PCT Pub. Date: Mar. 28, 1996 The invention relates to the use of Substantially fully 30 Foreign Application Priority Data destructurized Starch for transdermal applications in humans and animals, in particular the use of Solid particles Such as Sep. 21, 1994 NL Netherlands ........................... 94.01534 implants. The invention further relates to the implants manu (51) Int. Cl." ...................................................... A61F 13/00 factured of Substantially fully destructurized Starch, in addi 52 U.S. Cl. ........................... 424/422; 424/426; 424/488 tion to methods for manufacturing the implants. 58 Field of Search ..................................... 424/422, 426, 424/488 15 Claims, 1 Drawing Sheet U.S. Patent Dec. 14, 1999 6,001,385 F.G. 1B 6,001,385 1 2 USE OF STARCH FORTRANSIDERMAL By “active ingredient' is meant in the broadest Sense any APPLICATIONS material which must be introduced into the human or animal body.
    [Show full text]
  • WO 2013/109323 A2 25 July 2013 (25.07.2013) W P O P C T
    (12) INTERNATIONAL APPLICATION PUBLISHED UNDER THE PATENT COOPERATION TREATY (PCT) (19) World Intellectual Property Organization International Bureau (10) International Publication Number (43) International Publication Date WO 2013/109323 A2 25 July 2013 (25.07.2013) W P O P C T (51) International Patent Classification: (81) Designated States (unless otherwise indicated, for every C07C 219/06 (2006.01) A61P 17/00 (2006.01) kind of national protection available): AE, AG, AL, AM, A61K 31/195 (2006.01) AO, AT, AU, AZ, BA, BB, BG, BH, BN, BR, BW, BY, BZ, CA, CH, CL, CN, CO, CR, CU, CZ, DE, DK, DM, (21) International Application Number: DO, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, GT, PCT/US20 12/060985 HN, HR, HU, ID, IL, IN, IS, JP, KE, KG, KM, KN, KP, (22) International Filing Date: KR, KZ, LA, LC, LK, LR, LS, LT, LU, LY, MA, MD, 19 October 2012 (19.10.2012) ME, MG, MK, MN, MW, MX, MY, MZ, NA, NG, NI, NO, NZ, OM, PA, PE, PG, PH, PL, PT, QA, RO, RS, RU, (25) Filing Language: English RW, SC, SD, SE, SG, SK, SL, SM, ST, SV, SY, TH, TJ, (26) Publication Language: English TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, ZA, ZM, ZW. (30) Priority Data: 61/549,80 1 2 1 October 20 11 (2 1.10.20 11) US (84) Designated States (unless otherwise indicated, for every kind of regional protection available): ARIPO (BW, GH, (71) Applicant (for all designated States except US): THE GM, KE, LR, LS, MW, MZ, NA, RW, SD, SL, SZ, TZ, UNIVERSITY OF NORTH CAROLINA AT CHAPEL UG, ZM, ZW), Eurasian (AM, AZ, BY, KG, KZ, RU, TJ, HILL [US/US]; 308 Bynum Hall, Campus 4105, Chapel TM), European (AL, AT, BE, BG, CH, CY, CZ, DE, DK, Hill, North Carolina 27599-4105 (US).
    [Show full text]
  • The Effect of Cytotoxic Chemotherapy on the Structural and Material Properties of Regenerate Bone in a Rabbit Model of Limb Lengthening
    The Effect of Cytotoxic Chemotherapy on the Structural and Material Properties of Regenerate Bone in a Rabbit Model of Limb Lengthening Fergal Monsell PhD Thesis University College London 2010 Table of Contents p.6 Declaration p.7 Acknowledgments p.8 Abstract Section 1 Osteogenic Sarcoma; Historical Perspectives, Current Concepts and the Aim of This Work p.10 1.1 Introduction p.11 1.2 Osteogenic sarcoma p.13 1.3 Multi-agent Chemotherapy in the Management of Osteogenic Sarcoma p.14 1.3.1 cis-Platinum and Adriamycin in the Treatment of Osteogenic Sarcoma p.15 1.3.2 cis-Platinum Pharmacology p.16 1.3.3 Side Effects of cis-Platinum p.17 1.3.4 Adriamycin Pharmacology p.18 1.3.5 Side Effects of Adriamycin p.18 1.3.6 Overview of the Role of Chemotherapy in the Management of Osteogenic Sarcoma p.19 1.4 Surgical Management of Osteogenic Sarcoma in Childhood p.19 1.4.1 Historical Perspective p.20 1.4.2 Allograft Reconstruction p.22 1.4.3 Vascularised Fibular Graft Reconstruction p.23 1.4.4 Rotationplasty p.24 1.4.5 Endoprosthetic Reconstruction p.24 1.4.6 Expandable Endoprosthetic Reconstruction p.25 1.4.7 Overview of the Surgical Management of Osteogenic Sarcoma p.26 1.5 Distraction Osteogenesis p.27 1.5.1 Historical Perspective p.27 1.5.2 The Biology of Distraction Osteogenesis p.29 1.6 Bone Transport p.29 1.6.1 Bone Transport for Traumatic Defects p.31 1.6.2 Bone Transport Following Benign Tumour Excision p.31 1.6.3 Bone Transport Following Malignant Tumour Excision p.32 1.6.4 Bone Transport in the Management of Ewing’s and Osteogenic Sarcoma
    [Show full text]
  • Thai Malta Mo a Una De La Cantara Man Unitate
    THAI MALTA MO AUS009808467B2 UNA DE LA CANTARA MAN UNITATE (12 ) United States Patent ( 10 ) Patent No. : US 9 ,808 , 467 B2 De Colle et al. (45 ) Date of Patent : Nov . 7 , 2017 ( 54 ) METHODS FOR TREATING GI TRACT ( 58 ) Field of Classification Search DISORDERS CPC . .. .. A61K 31/ 197 ; A61K 2300 / 00 ; A61K 31/ 198 ( 71 ) Applicant: Neurogastrx , Inc ., Campbell, CA (US ) USPC .. .. .. .. .. .. 514 /225 . 5 @ See application file for complete search history . ( 72 ) Inventors : Cyril De Colle , Campbell, CA (US ) ; Pankaj Pasricha , Ellicott City , MD (56 ) References Cited (US ) U . S . PATENT DOCUMENTS ( 73 ) Assignee : NEUROGASTRX , INC ., Campbell, 4 , 158 , 707 A 6 / 1979 Steffen et al . CA (US ) 4 , 309 , 421 A 1 / 1982 Ghyczy et al . 4 ,412 , 999 A 11 / 1983 Remy et al . ( * ) Notice : Subject to any disclaimer, the term of this 4 ,439 , 196 A 3 / 1984 Higuchi patent is extended or adjusted under 35 4 ,447 , 224 A 5 / 1984 DeCant , Jr. et al . U . S . C . 154 (b ) by 0 days . (Continued ) (21 ) Appl . No. : 14 /820 , 885 FOREIGN PATENT DOCUMENTS DE 2235998 AL 2 / 1973 ( 22 ) Filed : Aug . 7 , 2015 EP 2581085 A1 4 /2013 (65 ) ) Prior Publication Data (Continued ) US 2015 /0342958 A1 Dec . 3 , 2015 OTHER PUBLICATIONS Related U . S . Application Data Hershcovici and Fass , Trends Pharmacol Sci. Apr. 2011; 32 ( 4 ): 258 (63 ) Continuation of application No. 14 / 555, 455, filed on 64 . * Nov . 26 , 2014 , now Pat. No . 9 , 132 , 134 , which is a continuation of application No . (Continued ) PCT/ US2013 /076733 , filed on Dec . 19 , 2013 .
    [Show full text]
  • The Assault on Press Freedom in Poland by Annabelle Chapman CONTENTS
    June 2017 Pluralism Under Attack: The Assault on Press Freedom in Poland by Annabelle Chapman CONTENTS Pluralism Under Attack: The Assault on Press Freedom in Poland Foreword 1 1. Introduction 2 1.1 The political context 2 2. The Polish media landscape 4 2.1 The legal framework 4 2.2 The media landscape 4 2.3 Polarization and bias 6 2.4 The ownership structure of Polish media 8 3. The public media under PiS 9 3.1 The “small media law” 9 3.2 The National Media Council 10 3.3 The evening news 11 4. The private media under PiS 13 4.1 Access to the parliament 13 4.2 Advertising and distribution 13 5. Looking ahead 15 5.1 The regional dimension 15 5.2 The growing role of online media 15 6. Conclusion: Pluralism and the public interest 16 Pluralism Under Attack: The Assault on Press Freedom in Poland is made possible by the generous support of the JyllandsPosten Foundation. Freedom House is solely responsible for the content of this report. ABOUT THE AUTHOR ON THE COVER Annabelle Chapman is a Warsaw-based journalist writing Polish TV stations included “censorship” on their screens in for The Economist and other international publications. December 2016 to protest plans to restrict reporters' work in the parliament building. NurPhoto/Getty Foreword Pluralism Under Attack: The Assault on Press Freedom in Poland by Arch Puddington, Distinguished Fellow for Democracy Studies, Freedom House Press freedom has not fared well in the 21st century. Like all new democracies, the country had its deficien- According to Freedom of the Press, a report published cies.
    [Show full text]